Physician profile
J D Moskovitz
NPI 1407894587
$13,245.43
in general payments reported to CMS, 2019-2025
14 companies · $39.85 in 2025
The $39.85 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,991 · 2020: $7,737 · 2021: $606 · 2022: $275 · 2023: $351 · 2024: $247 · 2025: $39.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $12,477.92 | 2019-2023 | Penumbra System |
| Qapel Medical INC | $236.57 | 2023-2025 | |
| Balt USA, LLC | $124.07 | 2021 | |
| Kestra Medical Technology Services, INC. | $102.73 | 2024 | Assure Wcd |
| Boston Scientific Corporation | $72.80 | 2019-2025 | Farapulse |
| Abiomed | $39.82 | 2024 | Impella |
| Medtronic Vascular, INC. | $31.59 | 2019 | |
| W. L. Gore & Associates, INC. | $27.97 | 2021-2023 | Gore Viabahn Endoprosthesis With Heparin |
| Cardiva Medical, INC. | $26.47 | 2020 | |
| Biosense Webster, INC. | $26.42 | 2023 | Na |
| Cardiovascular Systems INC. | $23.12 | 2023 | Diamondback Peripheral |
| Abbott Laboratories | $22.27 | 2022 | |
| Bard Peripheral Vascular, INC. | $17.30 | 2023 | Venovo |
| Microvention, INC. | $16.38 | 2023 | Web Aneurysm Embolization System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Moskovitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.